ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 174 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $853,057 | -25.4% | 49,799 | -14.8% | 0.01% | -58.3% |
Q4 2022 | $1,143,867 | +94.2% | 58,450 | +58.3% | 0.01% | +140.0% |
Q1 2022 | $589,000 | -33.3% | 36,912 | -4.2% | 0.01% | -28.6% |
Q4 2021 | $883,000 | +193.4% | 38,518 | +453.8% | 0.01% | +133.3% |
Q2 2021 | $301,000 | -86.0% | 6,955 | -85.6% | 0.00% | -81.2% |
Q1 2021 | $2,145,000 | -65.6% | 48,346 | -48.9% | 0.02% | -20.0% |
Q4 2020 | $6,238,000 | – | 94,640 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |